Skip to content
  • Sunday, 26 July 2026
  • 1:43 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Takeda Ordered to Pay $885 Million in Landmark "Pay-for-Delay" Drug Case, Faces Potential $2.5 Billion Liability
Pharmaceutical R&D

Takeda Ordered to Pay $885 Million in Landmark "Pay-for-Delay" Drug Case, Faces Potential $2.5 Billion Liability

Teuku Ryan May 21, 2026 0

In a groundbreaking verdict that could reshape pharmaceutical antitrust litigation, a U.S. jury has found Japanese pharmaceutical giant Takeda liable…

Read More
Neuroscience & Brain Research

Case Western Reserve University Researchers Identify Gut Bacteria as a Key Driver in the Progression of ALS and Frontotemporal Dementia

Rifan Muazin May 5, 2026 0

Researchers at Case Western Reserve University have unveiled a groundbreaking study that identifies a profound and previously misunderstood link between…

Read More
Neuroscience & Brain Research

Gut Bacteria Sugars Identified as Potential Trigger for ALS and Frontotemporal Dementia in Breakthrough Case Western Reserve University Study

Rifan Muazin Apr 25, 2026 0

Researchers at Case Western Reserve University have unveiled a landmark discovery that identifies a specific molecular link between the human…

Read More
Pharmaceutical R&D

New Qulipta Study Data Bolsters Case Against Restrictive European Reimbursement Policies

Teuku Ryan Apr 25, 2026 0

New clinical trial results presented by AbbVie are poised to significantly influence the landscape of migraine prevention in Europe, providing…

Read More
Mass Spectrometry: The Unsung Hero Revolutionizing Vaccine Development and Global Health SecurityRethinking Artificial Intelligence in Cognitive Science as New Research Challenges the Centaur ModelTexas A&M University Researchers Develop Breakthrough Nasal Spray to Reverse Brain Aging and Combat Neurodegenerative DeclineTWiV 1293: The enemy of your parasite is your friend
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ